DGAP-News: SHOP APOTHEKE EUROPE announces result of convertible bond placement.
- 57
|
DGAP-News: SHOP APOTHEKE EUROPE N.V.
/ Key word(s): Issue of Debt/Financing
For further information, please follow the link:
https://shop-apotheke-europe.com/en/investorrelations/restricted/convertible-bonds_2021-01.html
14.01.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
| Language: | English |
| Company: | SHOP APOTHEKE EUROPE N.V. |
| Dirk Hartogweg 14 | |
| 5928 LV Venlo | |
| Netherlands | |
| Phone: | 0800 - 200 800 300 |
| Fax: | 0800 - 90 70 90 20 |
| E-mail: | [email protected] |
| Internet: | www.shop-apotheke-europe.com |
| ISIN: | NL0012044747, DE000A19Y072 |
| WKN: | A2AR94, A19Y07 |
| Indices: | MDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1160695 |
| End of News | DGAP News Service |
|
|
1160695 14.01.2021
EQS Group is a leading international technology provider for Digital Investor Relations, Corporate Communications and Compliance. More than 8,000 companies worldwide trust EQS’s products and services to securely, efficiently, and simultaneously fulfil complex national and international disclosure and compliance requirements, and to reach stakeholders globally.
